This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reinert, R. R.
Right arrow Articles by Al-Lahham, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reinert, R. R.
Right arrow Articles by Al-Lahham, A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2003, p. 489-493, Vol. 47, No. 2
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.2.489-493.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Macrolide-Resistant Streptococcus pneumoniae and Streptococcus pyogenes in the Pediatric Population in Germany during 2000-2001

Ralf René Reinert,1* Rudolf Lütticken,1 André Bryskier,2 and Adnan Al-Lahham1

National Reference Center for Streptococci, Institute for Medical Microbiology, University Hospital, D-52057 Aachen, Germany,1 Aventis Pharma, Hoechst Marion Roussel, Romainville, France2

Received 25 April 2002/ Returned for modification 10 July 2002/ Accepted 7 November 2002

In a nationwide study in Germany covering 13 clinical microbiology laboratories, a total of 307 Streptococcus pyogenes (mainly pharyngitis) and 333 Streptococcus pneumoniae (respiratory tract infections) strains were collected from outpatients less than 16 years of age. The MICs of penicillin G, amoxicillin, cefotaxime, erythromycin A, clindamycin, levofloxacin, and telithromycin were determined by the microdilution method. In S. pyogenes isolates, resistance rates were as follows: penicillin, 0%; erythromycin A, 13.7%; and levofloxacin, 0%. Telithromycin showed good activity against S. pyogenes isolates (MIC90 = 0.25 µg/ml; MIC range, 0.016 to 16 µg/ml). Three strains were found to be telithromycin-resistant (MIC >= 4 µg/ml). Erythromycin-resistant strains were characterized for the underlying resistance genotype, with 40.5% having the efflux type mef(A), 38.1% having the erm(A), and 9.5% having the erm(B) genotypes. emm typing of macrolide-resistant S. pyogenes isolates showed emm types 4 (45.2%), 77 (26.2%), and 12 (11.9%) to be predominant. In S. pneumoniae, resistance rates were as follows: penicillin intermediate, 7.5%; penicillin resistant, 0%; erythromycin A, 17.4%; and levofloxacin, 0%. Telithromycin was highly active against pneumococcal isolates (MIC90 <= 0.016 µg/ml; range, 0.016 to 0.5 µg/ml). The overall resistance profile of streptococcal respiratory tract isolates is still favorable, but macrolide resistance is of growing concern in Germany.

* Corresponding author. Mailing address: Institute for Medical Microbiology, National Reference Center for Streptococci, University Hospital, Pauwelsstrasse 30, D-52057 Aachen, Germany. Phone: 49-241-8089787. Fax: 49-241-8082483. E-mail: reinert{at}rwth-aachen.de.

Antimicrobial Agents and Chemotherapy, February 2003, p. 489-493, Vol. 47, No. 2
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.2.489-493.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Savini, V., Favaro, M., Fontana, C., Consilvio, N. P., Manna, A., Talia, M., Catavitello, C., Balbinot, A., Febbo, F., Di Bonaventura, G., Di Giuseppe, N., D'Antonio, D. (2008). A case of pharyngitis caused by Streptococcus pneumoniae. J Med Microbiol 57: 674-675 [Abstract] [Full Text]  
  • Rivera, A., Rebollo, M., Miro, E., Mateo, M., Navarro, F., Gurgui, M., Mirelis, B., Coll, P. (2006). Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain.. J Med Microbiol 55: 1115-1123 [Abstract] [Full Text]  
  • Grivea, I. N., Al-Lahham, A., Katopodis, G. D., Syrogiannopoulos, G. A., Reinert, R. R. (2006). Resistance to Erythromycin and Telithromycin in Streptococcus pyogenes Isolates Obtained between 1999 and 2002 from Greek Children with Tonsillopharyngitis: Phenotypic and Genotypic Analysis. Antimicrob. Agents Chemother. 50: 256-261 [Abstract] [Full Text]  
  • Creti, R., Gherardi, G., Imperi, M., von Hunolstein, C., Baldassarri, L., Pataracchia, M., Alfarone, G., Cardona, F., Dicuonzo, G., Orefici, G. (2005). Association of group A streptococcal emm types with virulence traits and macrolide-resistance genes is independent of the source of isolation. J Med Microbiol 54: 913-917 [Abstract] [Full Text]  
  • Haller, M., Fluegge, K., Arri, S. J., Adams, B., Berner, R. (2005). Association between Resistance to Erythromycin and the Presence of the Fibronectin Binding Protein F1 Gene, prtF1, in Streptococcus pyogenes Isolates from German Pediatric Patients. Antimicrob. Agents Chemother. 49: 2990-2993 [Abstract] [Full Text]  
  • Reinert, R. R., Al-Lahham, A. (2005). Time-Kill Study of the Activity of Telithromycin against Macrolide-Resistant Streptococcus pneumoniae Isolates with 23S rRNA Mutations and Changes in Ribosomal Proteins L4 and L22. Antimicrob. Agents Chemother. 49: 3011-3013 [Abstract] [Full Text]  
  • Poole, K. (2005). Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 56: 20-51 [Abstract] [Full Text]  
  • Littauer, P., Sangvik, M., Caugant, D. A., Hoiby, E. A., Simonsen, G. S., Sundsfjord, A., the Norwegian Macrolide Study Group, (2005). Molecular Epidemiology of Macrolide-Resistant Isolates of Streptococcus pneumoniae Collected from Blood and Respiratory Specimens in Norway. J. Clin. Microbiol. 43: 2125-2132 [Abstract] [Full Text]  
  • Reinert, R. R., Ringelstein, A., van der Linden, M., Cil, M. Y., Al-Lahham, A., Schmitz, F.-J. (2005). Molecular Epidemiology of Macrolide-Resistant Streptococcus pneumoniae Isolates in Europe. J. Clin. Microbiol. 43: 1294-1300 [Abstract] [Full Text]  
  • Fluegge, K., Supper, S., Siedler, A., Berner, R. (2004). Antibiotic Susceptibility in Neonatal Invasive Isolates of Streptococcus agalactiae in a 2-Year Nationwide Surveillance Study in Germany. Antimicrob. Agents Chemother. 48: 4444-4446 [Abstract] [Full Text]  
  • Kresken, M., Henrichfreise, B., Bagel, S., Brauers, J., Wiedemann, B. (2004). High Prevalence of the ermB Gene among Erythromycin-Resistant Streptococcus pneumoniae Isolates in Germany during the Winter of 2000-2001 and In Vitro Activity of Telithromycin. Antimicrob. Agents Chemother. 48: 3193-3195 [Abstract] [Full Text]  
  • Woo, P. C. Y., To, A. P. C., Lau, S. K. P., Fung, A. M. Y., Yuen, K.-y. (2004). Phenotypic and Molecular Characterization of Erythromycin Resistance in Four Isolates of Streptococcus-Like Gram-Positive Cocci Causing Bacteremia. J. Clin. Microbiol. 42: 3303-3305 [Abstract] [Full Text]  
  • Del Grosso, M., Scotto d'Abusco, A., Iannelli, F., Pozzi, G., Pantosti, A. (2004). Tn2009, a Tn916-Like Element Containing mef(E) in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 48: 2037-2042 [Abstract] [Full Text]  
  • Reinert, R. R. (2004). Clinical efficacy of ketolides in the treatment of respiratory tract infections. J Antimicrob Chemother 53: 918-927 [Abstract] [Full Text]  
  • Rendi-Wagner, P., Georgopoulos, A., Kundi, M., Mutz, I., Mattauch, M., Nowak, J., Mikolasek, A., Vecsei, A., Kollaritsch, H. (2004). Prospective surveillance of incidence, serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae among hospitalized children in Austria. J Antimicrob Chemother 53: 826-831 [Abstract] [Full Text]  
  • Reinert, R. R., Lutticken, R., Sutcliffe, J. A., Tait-Kamradt, A., Cil, M. Y., Schorn, H. M., Bryskier, A., Al-Lahham, A. (2004). Clonal Relatedness of Erythromycin-Resistant Streptococcus pyogenes Isolates in Germany. Antimicrob. Agents Chemother. 48: 1369-1373 [Abstract] [Full Text]  
  • Hasenbein, M. E., Warner, J. E., Lambert, K. G., Cole, S. E., Onderdonk, A. B., McAdam, A. J. (2004). Detection of Multiple Macrolide- and Lincosamide-Resistant Strains of Streptococcus pyogenes from Patients in the Boston Area. J. Clin. Microbiol. 42: 1559-1563 [Abstract] [Full Text]  
  • Otani, T., Tanaka, M., Ito, E., Kurosaka, Y., Murakami, Y., Onodera, K., Akasaka, T., Sato, K. (2003). In Vitro and In Vivo Antibacterial Activities of DK-507k, a Novel Fluoroquinolone. Antimicrob. Agents Chemother. 47: 3750-3759 [Abstract] [Full Text]  
  • Woo, P. C. Y., To, A. P. C., Tse, H., Lau, S. K. P., Yuen, K.-y. (2003). Clinical and Molecular Epidemiology of Erythromycin-Resistant Beta-Hemolytic Lancefield Group G Streptococci Causing Bacteremia. J. Clin. Microbiol. 41: 5188-5191 [Abstract] [Full Text]  
  • Reinert, R. R., Wild, A., Appelbaum, P., Lutticken, R., Cil, M. Y., Al-Lahham, A. (2003). Ribosomal Mutations Conferring Resistance to Macrolides in Streptococcus pneumoniae Clinical Strains Isolated in Germany. Antimicrob. Agents Chemother. 47: 2319-2322 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»